SCHEMBL7095480

SCHEMBL7095480

CC(CCCCCCCCC(C(=O)O)c1ccccc1)C(C)(C(=O)O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 2/20 0.44
CNR1 P21554 3/20 0.41
CNR2 P34972 3/20 0.41
CYP2C19 P33261 1/20 0.38
HDAC1 Q13547 3/20 0.36
HDAC7 Q8WUI4 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
MMP2 P08253 2/20 0.35
MMP3 P08254 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
CTSL P07711 1/20 0.34
CTSB P07858 1/20 0.34
CTSH P09668 1/20 0.34
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28469779 0.81 ALDH1A1 (0.43) CNR2CYP2C19HDAC1CYP1A2CYP2D6
SCHEMBL14360139 0.79 TBXAS1 (0.60) TBXAS1CYP2C19HDAC1HDAC7CYP2D6
Ammonia Solution, Strong SCHEMBL28562956 0.77 TBXAS1 (0.59) TBXAS1CYP2C19HDAC1HDAC7CYP2D6
Ammonia Solution, Strong SCHEMBL28556745 0.77 TBXAS1 (0.59) TBXAS1CYP2C19HDAC1HDAC7CYP2D6
SCHEMBL20986026 0.76 CYP2D6 (0.43) CNR1CNR2CYP2C19CYP1A2CYP2D6
SCHEMBL28807878 0.75 TBXAS1 (0.51) TBXAS1CYP2C19HDAC1HDAC7CYP2D6
SCHEMBL27360178 0.75 PPARA (0.48) TBXAS1CNR1CNR2CYP2C19SMN1; SMN2
SCHEMBL15474468 0.75 RIPK1 (0.50) TBXAS1CNR1CNR2CYP2C19HDAC1
SCHEMBL2550963 0.75 TBXAS1 (0.54) TBXAS1CNR2CYP2C19ALDH1A1LMNA
SCHEMBL2555641 0.75 TBXAS1 (0.54) TBXAS1CNR2CYP2C19ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326822-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-07-16 EP disclosed
WO-2002030860-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO disclosed